G Jones - Department of Gastroenterology, Western General Hospital- NHS Lothian

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis - a six-year follow-up study

B. Gros, H. Ross, M. Nwabueze,N. Constantine-Cooke, L. A. Derikx,M. Lyons, C. O'Hare,C. Noble,I. D. Arnott,G. R. Jones,C. W. Lees,N. Plevris

JOURNAL OF CROHNS & COLITIS (2024): I1582-I1584

引用0浏览0引用

An activity-based chemiluminescence assay targeting granzyme A for the detection of Inflammatory Bowel Diseases

J. Scott, E. Thompson, Z. Cheng, M. David, D. Gordon, L. Medive-Tapia,G. R. Jones, R. Hall, S. Chuah, B. Drury, A. Rossi, D. Shabat,

JOURNAL OF CROHNS & COLITIS (2024): I264-I265

引用0浏览0引用

Tofacitinib versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison

B. Gros,N. Constantine-Cooke, J. Kennedy, A. T. Elford, C. O'Hare,C. Noble,G. R. Jones,I. D. Arnott,N. Plevris,C. W. Lees

JOURNAL OF CROHNS & COLITIS (2024): I102-I103

引用0浏览0引用

P509 Surgery and biologic prescription rates for Crohn's disease in Lothian, Scotland; an updated population-based cohort study

P Jenkinson,N Plevris,M Lyons,B Gros Alcalde,L Derikx,N Constantine-Cooke,I Arnott,G Jones,C Lees

Journal of Crohn's and Colitisno. Supplement_1 (2023): 640-640

引用0浏览0引用

P557 Analysis of colectomy rates and advanced therapy prescribing for ulcerative colitis in Lothian; Scotland an updated population based cohort study

P Jenkinson,N Plevris,B Gros Alcalde,M Lyons,L Derikx,N Constantine-Cooke,I Arnott,G Jones,C Lees

Journal of Crohn's and Colitisno. Supplement_1 (2023): 687-688

引用0浏览0引用

P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years

R Porter, S L Gillespie, M Song, G Ball, A Crawford, A Churchhouse, M Gardner,N Plevris,C S Chuah,W Brindle,E Watson,P Jenkinson,

Journal of Crohn's and Colitisno. Supplement_1 (2023): I293-I293

引用0浏览0引用

P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy

Z Liu,J Alexander,K Le, X Zhou,H Ibraheim, S Anandabaskaran,A Saifuddin, K Lin, L Mcfarlane, N Anand,L Constable, R Castro-Seoane,

Journal of Crohn's and Colitisno. Supplement_1 (2023): 664-664

引用0浏览0引用

Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients

S. Lin,N. A. Kennedy,A. Saifuddin,D. Munoz Sandoval,C. J. Reynolds,R. C. Seoane,S. H. Kottoor,F. P. Pieper,K. M. Lin,D. K. Butler,N. Chanchlani,R. Nice,

Journal of Crohn's and Colitis（2022）

引用1浏览0引用

OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab

J Alexander,N Kennedy,H Ibraheim, S Anandabaskaran,A Saifuddin,R Castro Seoane,Z Liu,R Nice,C Bewshea,A D’Mello,L Constable,G R Jones,

Journal of Crohn's and Colitis（2022）

引用2浏览0引用

P489 Temporal trends of colectomy for ulcerative colitis in the multi-drug era; a population based cohort study

P Jenkinson,N Plevris,M Lyons, B Gros,L Derikx,N Constantine-Cooke,G Jones,C Lees

Journal of Crohn's and Colitis（2022）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn